Bloomberg
Celgene Corp. is nearing an accord to acquire closely held Impact Biomedicines Inc. to expand its presence in oncology, according to people familiar with the matter. An agreement could be announced as early as Monday, said the people, who asked not to
Celgene readies deal to buy Impact Biomedicines for as much as $7 billion: WSJReuters
Celgene Nears Deal to Buy Impact Biomedicines for as Much as $7 BillionWall Street Journal
Celgene might buy San Diego cancer drug developer for $7BThe San Diego Union-Tribune
Business Wire (press release)
all 7 news articles …read more

Source: Business